Evaluation of Immediate-Release Viloxazine in Adults With ADHD

NCT01107496 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

DRUG: IR Viloxazine
DRUG: Placebo

Sponsor

Supernus Pharmaceuticals, Inc.